A*STAR, NUS and global pharma companies ink MOU to develop pharma manufacturing sector

The Agency for Science, Technology and Research (A*STAR) and the National University of Singapore (NUS) signed a Memorandum of Understanding (MOU) with three leading pharmaceutical companies to mark the launch of an initiative to develop the country's pharma manufacturing sector. Named the Pharma Innovation Programme Singapore (PIPS), the initiative involved pioneer partners GSK, MSD International, and Pfizer Asia Pacific.

PIPS will focus on areas such as continuous manufacturing, bio-catalysis, process analytical technology and advanced process control. It will bring together Singapore's public sector research capabilities and the domain expertise of key players in the Pharma industry to improve and transform the manufacturing operations and technologies of the industry.

The MOU was endorsed at the inaugural Future of Manufacturing (FoM) Summit held on 5 September 2017.

<div>From left to right: Dr Prasad Kanneganti, Site Director, Pfizer Asia Pacific; Mr Lim Hock Heng, VP & Site Director, GSK; Mr John Smith, Managing Director of MSD International (Singapore Branch),</div><div> MSD Manufacturing Division Singapore; Mr Lim Chuan Poh, Chairman, A*Star; Mr S Iswaran, Minister for Trade and Industry (Industry); Prof Victor Shim, Vice-Dean (External Relations & Outreach), </div><div>NUS Engineering; and Mr Suresh Sachi, Deputy Managing Director, A*Star. Photo: A*STAR</div>

From left to right: Dr Prasad Kanneganti, Site Director, Pfizer Asia Pacific; Mr Lim Hock Heng, VP & Site Director, GSK; Mr John Smith, Managing Director of MSD International (Singapore Branch),

MSD Manufacturing Division Singapore; Mr Lim Chuan Poh, Chairman, A*Star; Mr S Iswaran, Minister for Trade and Industry (Industry); Prof Victor Shim, Vice-Dean (External Relations & Outreach),

NUS Engineering; and Mr Suresh Sachi, Deputy Managing Director, A*Star. Photo: A*STAR

<div>The signing of the MOU with Mr. S. Iswaran, Minister for Trade and Industry (Industry), and A*STAR Chairman, Mr. Lim Chuan Poh, as witnesses. From left to right: Mr John Smith, Managing Director,</div><div>MSD International (Singapore Branch), MSD Manufacturing Division Singapore; Mr Lim Hock Heng, Vice-President and Site Director, GSK; Mr Suresh Sachi, Deputy Managing Director, A*STAR;</div><div>Dr Prasad Kanneganti, Site Director, Pfizer Asia Pacific; and Prof Victor Shim, Vice-Dean (External Relations & Outreach), NUS Engineering. Photo: A*STAR</div>

The signing of the MOU with Mr. S. Iswaran, Minister for Trade and Industry (Industry), and A*STAR Chairman, Mr. Lim Chuan Poh, as witnesses. From left to right: Mr John Smith, Managing Director,

MSD International (Singapore Branch), MSD Manufacturing Division Singapore; Mr Lim Hock Heng, Vice-President and Site Director, GSK; Mr Suresh Sachi, Deputy Managing Director, A*STAR;

Dr Prasad Kanneganti, Site Director, Pfizer Asia Pacific; and Prof Victor Shim, Vice-Dean (External Relations & Outreach), NUS Engineering. Photo: A*STAR

Recent News

Why market-driven energy may work better in a crisis

Study by Assoc Prof Jimmy Peng suggests people prefer flexibility over equal rationing in emergency power distribution.

Presenting the 2024 CDE Alumni Award recipients

CDE celebrated the outstanding achievements of its alumni, recognising 15 individuals and two teams for their contributions.

Students unlock their entrepreneurial potential at CDE Innovation Day 2024

Eight student-led startup teams battled it out for the top prize